Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 4/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | PLG | P00747 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | MC4R | P32245 | 3/20 | 0.33 |
| ▸ | MC5R | P33032 | 3/20 | 0.33 |
| ▸ | MC3R | P41968 | 3/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.32 |
| ▸ | GABRR2 | P28476 | 3/20 | 0.32 |
| ▸ | GABRR3 | A8MPY1 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2152784 | 0.96 | ALDH1A1 (0.41) | ALDH1A1CYP2D6NFKB1BLMNPSR1 | |
| SCHEMBL2044848 | 0.88 | ALDH1A1 (0.50) | ALDH1A1LMNAKMT2AMEN1TSHR | |
| Hydrochloric Acid SCHEMBL2152108 | 0.84 | ALDH1A1 (0.42) | ALDH1A1BLMNPSR1LMNAKMT2A | |
| SCHEMBL2159395 | 0.81 | ZDHHC20 (0.46) | ALDH1A1TSHR | |
| SCHEMBL15103224 | 0.81 | ABCC4 (0.48) | ALDH1A1LMNATSHR | |
| SCHEMBL15941291 | 0.80 | ALDH1A1 (0.47) | ALDH1A1LMNAKMT2AMEN1CYP1A2 | |
| SCHEMBL31040409 | 0.79 | LMNA (0.48) | ALDH1A1CYP2D6NFKB1BLMNPSR1 | |
| SCHEMBL13692258 | 0.79 | NFKB1 (0.44) | ALDH1A1CYP2D6NFKB1BLMNPSR1 | |
| Hydrochloric Acid SCHEMBL11264305 | 0.78 | ZDHHC20 (0.47) | ALDH1A1KMT2AMEN1ALOX15TSHR | |
| Hydrochloric Acid SCHEMBL25202141 | 0.77 | BLM (0.46) | ALDH1A1CYP2D6NFKB1BLMNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11091517-B2 | Peptide derivative and pharmaceutical composition containing same | TOKUSHIMA UNIVERSITY (JP) | 2021-08-17 | — | — | US | disclosed |
| US-20200255474-A1 | PEPTIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | TOKUSHIMA UNIVERSITY (JP) | 2020-08-13 | — | — | US | disclosed |
| US-10669310-B2 | Peptide for cancer treatment and pharmaceutical composition containing same | TOKUSHIMA UNIVERSITY (JP) | 2020-06-02 | — | — | US | disclosed |
| EP-3656783-A1 | PEPTIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Tokushima University (JP) | 2020-05-27 | — | — | EP | disclosed |
| US-20190023739-A1 | PEPTIDE FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | TOKUSHIMA UNIVERSITY (JP) | 2019-01-24 | — | — | US | disclosed |
| EP-3406626-A1 | PEPTIDE FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Tokushima University (JP) | 2018-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200255474-A1 | PEPTIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | PHB2, PHB1, BBC3 | ALDH1A1 4828/4885CYP2D6 4688/4885NFKB1 2708/4885 |
| US-20190023739-A1 | PEPTIDE FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | PHB2, PHB1, BBC3 | ALDH1A1 4840/4885CYP2D6 4776/4885NFKB1 3093/4885 |
| US-11091517-B2 | Peptide derivative and pharmaceutical composition containing same | PHB2, PHB1, BBC3 | ALDH1A1 4828/4885CYP2D6 4688/4885NFKB1 2708/4885 |
| US-10669310-B2 | Peptide for cancer treatment and pharmaceutical composition containing same | PHB2, PHB1, BBC3 | ALDH1A1 4840/4885CYP2D6 4776/4885NFKB1 3093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.